These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1831655)

  • 1. Autoreactive T-cell clones which suppress cytotoxic T cell responses.
    Sakatsume M; Harada Y; Ling X; Yasumoto A; Kurosu A; Koseki H; Saito T; Kantake M; Taniguchi M
    Int Immunol; 1991 Apr; 3(4):377-84. PubMed ID: 1831655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GM3 ganglioside as melanoma specific antigen and its biological function].
    Hirabayashi Y; Taniguchi M
    Hum Cell; 1989 Mar; 2(1):63-9. PubMed ID: 2535260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escape mechanisms of melanoma from immune system by soluble melanoma antigen.
    Takahashi K; Ono K; Hirabayashi Y; Taniguchi M
    J Immunol; 1988 May; 140(9):3244-8. PubMed ID: 2452202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density of GM3 with normal primary structure determines mouse melanoma antigenicity; a new concept of tumor antigen.
    Harada Y; Sakatsume M; Nores GA; Hakomori S; Taniguchi M
    Jpn J Cancer Res; 1989 Oct; 80(10):988-92. PubMed ID: 2533193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of melanoma antigen and its involvement in tumor-escape mechanisms.
    Taniguchi M; Sakatsume M; Harada Y; Nores GA; Hakomori S
    Princess Takamatsu Symp; 1988; 19():247-54. PubMed ID: 2978619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mouse anti-melanoma cytotoxic and suppressor T cells in vitro by an artificial antigen, GM3-lactone.
    Harada Y; Sakatsume M; Taniguchi M
    Jpn J Cancer Res; 1990 Apr; 81(4):383-7. PubMed ID: 2142151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. I. Destruction of B16 melanoma cells mediated by bystander cytolysis in vitro.
    Shiohara T; Ruddle NH; Horowitz M; Moellmann GE; Lerner AB
    J Immunol; 1987 Mar; 138(6):1971-8. PubMed ID: 3102609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.
    Ottenhoff TH; Mutis T
    J Exp Med; 1990 Jun; 171(6):2011-24. PubMed ID: 1972178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse melanoma antigen recognized by Lyt-2- and L3T4- cytotoxic T-lymphocytes.
    Ono K; Takahashi K; Hirabayashi Y; Itoh T; Hiraga Y; Taniguchi M
    Cancer Res; 1988 May; 48(10):2730-3. PubMed ID: 2452012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
    Gervois N; Heuze F; Diez E; Jotereau F
    Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction of mouse CD8+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms.
    Inoue T; Asano Y; Matsuoka S; Furutani-Seiki M; Aizawa S; Nishimura H; Shirai T; Tada T
    J Immunol; 1993 Mar; 150(6):2121-8. PubMed ID: 8450205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of immune responses by cloned T cells and their products.
    Tada T; Inoue T; Asano Y
    Behring Inst Mitt; 1992 Apr; (91):78-86. PubMed ID: 1388020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4.
    Paliard X; Yssel H; Blanchard D; Waitz JA; deVries JE; Spits H
    J Immunol; 1989 Jul; 143(2):452-7. PubMed ID: 2472439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. Recognition of TCR-gamma delta+ CTL clones is affected by mutations at positions 152 and 156.
    Spits H; Paliard X; Engelhard VH; de Vries JE
    J Immunol; 1990 Jun; 144(11):4156-62. PubMed ID: 2111341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific CD4(+) suppressor T-cell clone capable of inhibiting rejection of syngeneic sarcoma in A/J mice.
    Fu T; Shen Y; Fujimoto S
    Int J Cancer; 2000 Sep; 87(5):680-7. PubMed ID: 10925362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis.
    Mazzocchi A; Rodolfo M; Parmiani G; Anichini A
    Melanoma Res; 1991; 1(3):169-76. PubMed ID: 1841713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones.
    Rivas A; Koide J; Cleary ML; Engleman EG
    J Immunol; 1989 Mar; 142(6):1840-6. PubMed ID: 2466078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.